The plant biotechnology flight: Is Africa on board?

African Journal of Biotechnology

Volumn 9, Issue 28, 2010, Pages 4300-4308

  Obembe, Olawole O ^a,b  

^a Centre for Economic Policy and Development Research   (Nigeria)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

African biotech capacity building; African biotechnology; Developing countries; Molecular farming

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMYLASE; AVIDIN; BACTERIAL ANTIGEN; CANCER VACCINE; CAPSID PROTEIN; CHOLERA TOXIN B SUBUNIT; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; FIBRINOLYTIC AGENT; GLUCOSYLCERAMIDASE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOSPHERE; INSULIN; LACTOFERON; LACTOFERRIN; LIPASE B; LYSOZYME; MERISPASE; MONENSIN; MONOCLONAL ANTIBODY; NEW CASTLE DISEASE VACCINE; NUTRACEUTICAL; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VETERINARY DRUG; VIRUS VACCINE;

AFRICA; ARTICLE; BIRD DISEASE; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; COMMON COLD; CYANOCOBALAMIN DEFICIENCY; CYSTIC FIBROSIS; DEVELOPING COUNTRY; DIABETES MELLITUS; DIARRHEA; DOG DISEASE; DRUG INDUSTRY; GAUCHER DISEASE; GENE EXPRESSION SYSTEM; GENETIC ENGINEERING; GENETIC TRANSFORMATION; GLYCOSYLATION; HEPATITIS B; HEPATITIS C; HORSE DISEASE; HUMAN; INFECTION; INFLAMMATION; MAIZE; MOLECULAR FARMING; NONHODGKIN LYMPHOMA; NONHUMAN; PLANT BIOTECHNOLOGY; PLANT GENETICS; PLANT TISSUE CULTURE; POTATO; PROTEIN PROCESSING; RICE; SAFFLOWER; SCALE UP; TOBACCO; TRANSGENIC PLANT;

EID: 77954963879     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Andersen DC, Krummen L (2002). Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol. 13: 117-123.
2. Arlen PA, Falconer R, Cherukumilli S, Cole A, Cole AM, Oishi KK, Daniell H (2007). Field production and functional evaluation of chloroplast derived interferon-α2b. Plant Biotechnol. J. 5: 511-525.
3. Ayele S, Chataway J, Wield D (2006). Partnerships in African crop biotech. Nat. Biotechnol. 24: 619-621.
4. Bai JY, Zeng L, Hu YL, Li YF, Lin ZP, Shang SC, Shi YS (2007). Expression and characteristic of synthetic human epidermal growth factor (hEGF) in transgenic tobacco plants. Biotechnol. Lett. 29: 2007-2012.
5. Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch D (2001). Galactoseextended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. USA, 98: 2899-2904.
6. Barta A, Sommengruber K, Thompson D, Hartmuth K, Matzke M, Matzke A (1986). The expression of a napoline synthase human growth hormone chimeric gene in transformed tobacco and sunflower callus tissue. Plant Mol. Biol. 6: 347-357.
7. Basaran P, Rodríguez-Cerezo E (2008). Plant Molecular Farming: Opportunities and Challenges. Crit. Rev. Biotechnol. 28: 153-172.
8. Bennett RM, Kambhampati U, Morse S, Ismael Y (2006). Farm-level economic performance of genetically modified cotton in Maharashtra, Indian. Rev. Agric. Econ. 28: 59-71.
9. Biemelt S, Sonnewald U (2005). Molecular Farming in Plants. In: Nature Encyclopedia of Life Sciences. London: Nature Publishing Group, http://www.els.net/ doi:10.1038/npg.els.0003365
10. Cabanes-Macheteau M, Fitchette-Lainé AC, Loutelier-Bourhis C, Lange C, Vine ND, Ma JK, Lerouge P, Faye L (1999). N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology, 9: 365-72.
11. Cohen JI (2005). Poorer nations turn to publicly developed GM crops. Nat. Biotechnol. 23: 27-33.
12. Costa-Font J, Mossialos E (2005). Ambivalent individual preferences towards biotechnology in the European Union: products or processes? J. Risk Res. 8(4): 341-354.
13. Decker EL, Reski R (2004). The moss bioreactor. Curr. Opin. Plant Biol. 7: 166-170.
14. Delmer DP (2005). Agriculture in the developing world: Connecting innovations in plant research to downstream applications Proc. Natl. Acad. Sci. USA, 102: 15739-15746.
15. Diaz de la Garza RI, GregoryJF III, Hanson AD (2007). From the cover: Foiate biofortification of tomato fruit. Proc. Natl. Acad. Sci. USA, 104: 4218-1222.
16. Edelbaum O, Stein D, Holland N, Gafni Y, Livneh O, Novick D, Rubinstein M, Sela I (1992). Expression of active human interferonbeta in transgenic plants. J. Interferon Res. 12: 449-453.
17. Elias-Lopez AL, Marquina B, Gutierrez-Ortega A, Aguilar D, Gomez-Lim M, Hernandez-Pando R (2008). Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis. Clin. Exp. Immunol. 154: 123-133.
18. Fitt GP (2003). Implementation and impact of transgenic Bt cottons in Australia. The ICAC Recorded 21: 14-119.
19. Fønnebø V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launsø L, Koithan M, Falkenberg T, Boon H, Aickin M (2007). Researching complementary and alternative treatments - the gatekeepers are not at home. BMC Med. Res. Methodol. 7: p. 7.
20. Gianessi LP, Silvers CS, Sankula S, Carpenter JE (2002). Plant Biotechnology: Current and Potential Impact for Improving Pest Management in US Agriculture: An Analysis Of 40 Case Studies, National Center For Food Agric Policy.
21. Gutiérrez-Ortega A, Sandoval-Montes C, Olivera-Flores TJ, Santos-Argumedo L, Gómez-Lim MÁ (2005). Expression of functional interleukin-12 from mouse in transgenic tomato plants. Transgenic Res. 14: 877-885.
22. Haq TA, Mason HS, Clements JD, Arntzen C (1995). Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science, 268: 714-716.
23. Harvey AJ, Speksnijder G, Baugh LR, Morris JA, Ivarie R (2002). Expression of exogenous protein in the egg white of transgenic chickens. Nat. Biotechnol. 20: 396-399.
24. He Z, Jiang XL, Qi Y, Di QL (2008). Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression. Genetica, 133: 207-214.
25. Hiatt A, Cafferkey R, Bowdish K (1989). Production of antibodies in transgenic plants. Nature, 342: 76-78.
26. Hood EE, Witcher DR, Maddock S, Meyer T, Baszczynski C, Bailey M, Flynn P, Register J, Marshall L, Bond D, Kulisek E, Kusnadi AR, Evangelista R, Nikolov ZL, Wooge C, Mehigh RJ, Hernan R, Kappel WK, Ritland D, Li CP, Howard JA (1997). Commercial production of avidin from transgenic maize: Characterization of transformant production, processing, extraction and purification. Mol. Breed. 3: 291-306.
27. Huang J, Hu R, Pray C, Qiao F, Rozelle S (2003). Bt cotton benefits, costs, and impacts in China. AgBioForum 5: 1-14.
28. Huang Z, Dry I, Webster D, Strugnell R, Wesselingh S (2001). Plantderived measles virus Hemagglutinin protein induces neutralizing antibodies in mice. Vaccine, 19: 2163-2171.
29. Huether CM, Lienhart O, Baur A, Stemmer C, Gorr G, Reski R, Decker EL (2005). Glyco-engineering of moss lacking plant-specific sugar residues. Plant Biol. 7: 292-299.
30. Hull AK, Criscuolo CJ, Mett V, Groen H, Steeman W, Westra H, Chapman G, Legutki B, Baillie Les, Yusibov V (2005). Humanderived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine, 23: 2082-2086.
31. Kaiser J (2008). Is the drought over for pharming? Science, 320: 473-475.
32. Key S, Ma JKC, Drake PMW (2008). Genetically modified plants and human health. J. R. Soc. Med. 101: 290-298.
33. Konde V (2006).The Biotechnology Revolution and its Implication for Food Security in Africa. In: ATPS Special Paper Series no. 28. Narobi, African Technology Policy Studies Network/ Newtec Concepts.
34. Lau OS, Sun SSM (2009). Plant seeds as bioreactors for recombinant protein production. Technological Advance doi:10.1016/j.biotechadv.2009.05.005.
35. Lee D, Chen A, Nair R (2008). Genetically Engineered Crops for Biofuel Production: Regulatory Perspectives. Biotechnol. Gen. Eng. Rev. 25: 331-362.
36. Liu HL, Li WI, Lei T, Zheng J, Zhang Z, Yan XF, Wang ZZ, Wang YL, Si LS (2005). Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants. Acta. Biochim. Biophys. Sin (Shanghai) 37: 153-158.
37. Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K, Lehner T (1995). Generation and assembly of secretory antibodies in plants. Science, 268: 716-719.
38. Machuka J (2001). Agricultural Biotechnology for Africa. African Scientists and Farmers Must Feed Their Own People. Plant Physiol. 126: 16-19.
39. Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson A-L, Rybicki EP (2007). Optimization of human papillomavirus type 16 (HPV-16) L1. expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J. Gen. Virol. 88: 1460-1469.
40. Marquet-Blouin E, Bouche FB, Steinmetz A, Muller CP (2003). Neutralizing immunogenicity of transgenic carrot (Daucus carota L.) - derived measles virus hemagglutinin. Plant Mol. Biol. 51: 459-469.
41. Mason HS, Lam DM, Arntzen CJ (1992). Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA, 89: 11745-11749.
42. Mayfield SP, Franklin SE, Lerner RA (2003). Expression and assembly of a fully active antibody in algae. Proc. Natl. Acad. Sci. USA, 100: 438-442.
43. McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tusé D, Levy R (2008). Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc. Natl. Acad. Sci. USA, 105: 10131-10136.
44. Mett V, Lyons J, Musiychuk, Chichester JA, Brasil T, Couch KR, Sherwood R, Palmer GA, Streatfield SJ, Yusibov V (2007). A plantproduced plague vaccine candidate confers protection to monkeys. Vaccine, 25: 3014-3017.
45. Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T (2007). Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine, 25: 1647-57.
46. Morse S, Bennett R, Ismael Y (2005). Bt-cotton boosts the gross margin of small-scale cotton producers in South Africa. Int. J. Biotechnol. 7: 72-83.
47. Musa TA, Hung CY, Darlington DE, Sane DC, Xie J (2009). Overexpression of human erythropoietin in tobacco does not affect plant fertility or morphology. Plant Biotechnol. Rep. 3: 157-165.
48. Nicholson L, Gonzalez-Melendi P, van Dolleweerd C, Tuck H, Perrin Y, Ma JK, Fischer R, Christou P, Stoger E J (2005). A recombinant multimeric immunoglobulin expressed in rice shows assemblydependent subcellular localization in endosperm cells. Plant Biotechnol. 3: 115-127.
49. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H (2007). Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. USA, 104: 10986-10991.
50. Nykiforuk CL, Boothe JG, Murray EW, Keon RG, Goren HJ, Markley NA, Moloney MM (2006). Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol. J. 4: 77-85.
51. Obembe OO, Dike IP (2009). India's biotechnology boom: A lesson for Africa. Presented at the 3rd Knowledge Management Africa 2009 Conference, 4-7 May, 2009, Dakar, Senegal.
52. Obembe OO, Jacobsen E, Visser RGF, Vincken JP (2007a). Expression of an expansin carbohydrate-binding module affects xylem and phloem formation. Afr. J. Biotechnol. 6: 1608-1616.
53. Obembe OO, Jacobsen E, Timmers J, Gilbert H, Blake AW, Knox JP, Visser RGF, Vincken JPv (2007b). Promiscuous, non-catalytic, tandem carbohydrate-binding modules modulate the cell-wall structure and development of transgenic tobacco (Nicotiana tabacum) plants. J. Plant Res, 120: 605-617.
54. Oey M, Lohse M, Kreikemeyer B, Bock R (2009). Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J. 57: 436-445.
55. Ozor N (2008). Challenges and impacts of agricultural biotechnology on developing societies. Afr. J. Biotechnol. 7: 322-330.
56. Paarlberg RL (2008). Starved for science: how biotechnology is being kept out of Africa. Harvard University Press.
57. Pen J, van Ooyen AJJ, van den Elzen PJM, Rietveld K, Hoekema A (1992). Direct screening for high-level expression of an introduced α-amylase gene in plants. Plant Mol. Biol. 18: 1133-1139.
58. Pujol M, Ramírez NI, Ayala M, Gavilondo JV, Valdés R, Rodríguez M, Brito J, Padilla S, Gómez L, Reyes B, Peral R, Pérez M, Marcelo JL, Milá L, Sánchez RF, Páez R, Cremata JA, Enríquez G, Mendoza, Ortega MO, Borroto C (2005). An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine, 23: 1833-1837.
59. Qaim M (2003). Bt cotton in India: field trial results and economic projections. World Dev. 31: 2115-2127.
60. Qian B, Shen H, Liang W, Guo X, Zhang C, Wang Y, Li G, Wu A, Cao K, Zhang D (2008). Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds. Transgenic Res. 17: 621-631.
61. Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, Labrou N, Altmann F, Ma J, Stöger E, Capell T, Christou P (2008). Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc. Natl. Acad. Sci. USA, 105: 3727-3732.
62. Rosales-Mendoza S, Alpuche-Solis AG, Soria-Guerra RE, Moreno-Fierros L, Martnez-Gonzalez L, Herrera-Diaz A, Korban SS (2009). Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. Plant J. 57: 45-54.
63. Ruggiero F, Exposito JY, Bournat P, Gruber V, Perret S, Comte J, Olagnier B, Garrone R, Theisen M (2000). Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett. 469: 132-136.
64. Rybicki EP (2009). Plant-produced vaccines: promise and reality. Drug Discov. Today, 14: 16-24.
65. Sadhu L, Reddy VS (2003). Chloroplast expression of His-tagged GUSfusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors Mol. Breed, 11: 49-58
66. Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS (2006). Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc. Natl. Acad. Sci. USA, 103: 861-866.
67. Satyavathi VV, Prasad V, Abha K, Shaila MS, Lakshmi SG (2003). Expression of Hemagglutinin protein of Rinderpest virus in transgenic pigeon pea [Cajanus cajan (L.) Millsp.] plants. Plant Cell Rep. 21: 651-658.
68. Schillberg S, Twyman RM, Fischer R (2005). Opportunities for recombinant antigen and antibody expression in transgenic plantstechnology assessment. Vaccine, 23: 1764-1769.
69. Schillberg S, Twyman RM (2007). Pharma-Planta: Recombinant Pharmaceuticals from Plants for Human health Pharming. In Engelhard M, Hagen K, Felix Thiele F (eds.) A New Branch of Biotechnology, Graue Reihe Nr. 43 Bad Neuenahr-Ahrweiler GmbH Europäische Akademie.
70. Sharma AK, Sharma MK (2009). Plants as bioreactors: Recent developments and emerging opportunities. Biotechnol. Adv. doi:10.1016/j. biotechadv.2009,06.004.
71. Sharma MK, Singh NK, Jani D, Sisodia R, Thungapathra M, Gautam JK, Meena LS, Singh Y, Ghosh A, Tyagi AK, Sharma AK (2008). Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to choleratoxin B subunit in transgenic tomato (Solanumlycopersicum). Plant Cell Rep. 27: 307-318.
72. Shepherd DN, Mangwende T, Martin DP, Bezuidenhout M, Kloppers FJ, Carolissen CH, Monjane AL, Rybicki EP, Thomson JA (2007). Maize streak virus-resistant transgenic maize: a first for Africa. Plant Biotechnol. J. 5: 759-767.
73. Sijmons PC, Dekker BMM, Schrammeijer B, Verwoerd TC, van den Elzen PJM, Hoekema A (1990). Production of correctly processed human serum albumin in transgenic plants. Biotechnology, 8: 217-221.
74. Singh JA, Daar AS (2008). The 20-year African biotech plan. Nat. Biotechnol. 26: 272-274.
75. Sinha G (2007). GM technology develops in the developing world. Science, 315: 182-183.
76. Spök A, Twyman RM, Fischer R, Ma JKC, Sparrow PAC (2008). Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol. 26: 506-17.
77. Staub JM, Garcia B, Graves J, Hajdukiewicz PT, Hunter P, Nehra N, Paradkar V, Schlittler M, Carroll JA, Spatola L, Ward D, Ye G, Russell DA (2000). High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 18: 333-338.
78. Sticklen MB (2008). Plant genetic engineering for biofuel production: towards affordable cellulosic ethanol. Nat. Rev. Gen. 9: 433-443.
79. Streatfield SJ, Howard JA (2003). Plant-based vaccines. Int. J. Parasitol. 33: 479-493.
80. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000). Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182: 302-305.
81. Tacket CO, Mason HS, Losonsky, G, Clements JD, Levine MM, Arntzen CJ (1998). Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. J. Nat. Med. 4: 607-609.
82. Thomson JA (2008). The role of biotechnology for agricultural sustainability in Africa. Philos Trans. R. Soc. Lond. B, 363: 905-913.
83. Tiwari S, Verma PC, Singh PK, Tuli (2009). R Plants as bioreactors for the production of vaccine antigens. Biotechnol. Adv. 27: 449-467.
84. Tregoning JS, Clare S, Bowe F, Edwards L, Fairweather N, Qazi O, Nixon PJ, Maliga P, Dougan G, Hussell T (2005). Protection against tetanus toxin using a plant-based vaccine. Eur. J. Immunol. 35: 1320-1326.
85. Varsani A, Williamson AL, Stewart D, Rybicki EP (2006). Transient expression of human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Res. 120: 91-96.
86. Vermin P, Waltz E (2006). USDA approves the first plant-based vaccine. Nature, 24:233-234.
87. Vézina LP, Faye L, Lerouge P, D'Aoust MA, Marquet-Blouin E, Burel C, Lavoie PO, Bardor M, Gomord V (2009). Transient co-expression for fast and high-yield production of antibodies with human-like Nglycans in plants. Plant Biotechnol. J. 7: 442-455.
88. Villani ME, Morgun B, Brunetti P, Marusic C, Lombardi R, Pisoni I, Bacci C, Desiderio A, Benvenuto E, Donini M (2008). Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnol. J. 6: 000-000 doi: 10.1111/j.1467-7652.2008.00371.x
89. Wambugu F (1999). Why Africa needs agricultural biotechnology. Nature, 400: 15-16.
90. Weise A, Altmann F, Rodríguez-Franco M, Sjoberg ER, Baumer W, Launhardt H, Kietzmann M, Gorr G (2007). High-level expression of secreted complex glycosylate recombinant human erythropoietin in the Physcomitrella D-fuc-t D-xyl-t mutant. Plant Biotechnol. J. 5: 389-401.
91. Woodard SL, Mayor JM, Bailey MR, Barker DK, Love RT, Lane JR, Delaney DE, McComas-Wagner JM, Mallubhotla HD, Hood EE, Dangott LJ, Tichy SE, JA Howard JA (2003). Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol. Appl. Biochem. 38: 123-130.
92. Ye X, Al-Babili S, Kloti A, Zhang 1, Lucca P, Beyer P, Potrykus I (2000). Engineering the provitamin A (β-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science, 287: 303-305.
93. Yu J, Langridge WHR (2001). A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol., 19: 548-552.
94. Zhang X, Urry DW, Daniell H (1996). Expression of an environmentally friendly synthetic protein-based polymer gene in transgenic tobacco plants. Plant Cell Rep. 16: 174-179.